期刊文献+

警惕注射用醋酸卡泊芬净的严重不良反应 被引量:1

Serious adverse reactions to injection of caspofungin acetate
下载PDF
导出
摘要 醋酸卡泊芬净一般不良反应是轻微的,由于其在国内上市时间不是太长,临床应用经验有限,所以其有关不良反应的报道不多,随着该药物临床应用的增加,其存在一些少见的不良反应陆续地被报道出来,可能对患者产生严重后果。 General adverse reactions to the injection of caspofungin acetate are mild. Due to the short time for the drug used in domestic and the limited experience of clinical application, the relevant reports of ad- verse reactions to the drug is not so much. With the accumulation of clinical data, we found that the use of caspofungin acetate may lead to some rare adverse reation and cause some serious consequences to patients.
出处 《中国实用医药》 2012年第35期128-128,共1页 China Practical Medicine
关键词 注射用醋酸卡泊芬净 严重不良反应 Injection of caspofungin acetate Serious adverse reaction
  • 相关文献

参考文献7

二级参考文献13

  • 1Julia Lynch,Annie Wong-Beringer,席瑜钦.卡泊芬净引起严重可逆性血小板减少[J].中国处方药,2005,4(2):75-77. 被引量:4
  • 2MICROMEDEX(R)[S].Healthcare Series Vol.124 quarter 2/2005
  • 3ABRUZZO G K,FLATTERY AM,GILL C J,et al.Evaluation of the echinocandin antifungal MK-0991 (L-743,872):efficacies in mouse models of disseminated aspergillosis,candidiasis,and cryptococcosis[J].Antimicrob Agents Chemother,1997,41(11):2333-2338.
  • 4ABRUZZO G K,GILL C J,FLATTERY A M,et al.Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice[J].Antimicrob Agents Chemother,2000,44 (9):2310-2318.
  • 5HERNANDEZ S,SOPEZ-RIBOT J L,NAJVAR L K,et al.Caspofungin resistance in Candida albicans:correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis[J].Antimicrob Agents Chemother,2004,48(4):1382-1383.
  • 6VILLANUEVA A,GOTUZZO E,ARATHOON E G,et al.A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis[J].Am J Med,2002,113:294-299.
  • 7MORA-DUARTE J,BETTS R,ROTSTEIN C,et al.Comparison of caspofungin and amphotericin B for invasive candidiasis[J].N Engl J Med,2002,347:2020-2029.
  • 8THOMAS J,WALSH M D,HEDY T,et al.Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia[J].N Engl J Med,2004,351 (9):1391-1402.
  • 9BOOGAERTS MA,MAERTENS.J,Van DerGeest R,et al.Phamacokine tics and safety of a 7-day adminstation of intravenous itvaconazole followed by a 14-day adminstration of itraconazole oral solution in patients with hematilogic malignancy[J].Antimicrob Agents Chemother,2001,45 (3):981-985.
  • 10JOHNSON LB,KAUFFMAN CA.Voriconazole:a new triazole antifungal agent[J].Clin Infect Dis,2003,36(5):630-637.

共引文献31

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部